Results 1 to 10 of about 242,220 (201)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer

open access: yesCells, 2021
RNA splicing is a critical step in the maturation of precursor mRNA (pre-mRNA) by removing introns and exons. The combination of inclusion and exclusion of introns and exons in pre-mRNA can generate vast diversity in mature mRNA from a limited number of ...
Keisuke Nimura, Koji Kitamura
exaly   +4 more sources

Detection of Aberrant Splicing Events in RNA-Seq Data Using FRASER

open access: yesNature Communications, 2021
Aberrant splicing is a major contributor to rare disease, but detection accuracy using current methods is limited. Here, the authors develop an algorithm that detects aberrant splicing and intron retention events from RNA-seq data and apply it to ...
Vicente A Yépez   +2 more
exaly   +3 more sources

Aberrant Alternative Splicing Is Another Hallmark of Cancer [PDF]

open access: yesInternational Journal of Cell Biology, 2013
The vast majority of human genes are alternatively spliced. Not surprisingly, aberrant alternative splicing is increasingly linked to cancer. Splice isoforms often encode proteins that have distinct and even antagonistic properties.
Michael Ladomery
doaj   +2 more sources

Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer

open access: yesHeliyon, 2023
The contribution of oncogenes to tumor-associated RNA splicing and the relevant molecular mechanisms therein require further elaboration. Here, we show that oncogenic Aurora kinase A (AURKA) promotes breast cancer-related RNA aberrant splicing in a ...
Sisi Li   +7 more
doaj   +2 more sources

Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes. [PDF]

open access: yesPLoS ONE, 2013
Aberrant pre-mRNA splice variants of hyaluronan synthase 1 (HAS1) have been identified in malignant cells from cancer patients. Bioinformatic analysis suggests that intronic sequence changes can underlie aberrant splicing.
Jitra Kriangkum   +3 more
doaj   +2 more sources

A method of predicting changes in human gene splicing induced by genetic variants in context of cis-acting elements [PDF]

open access: yesBMC Bioinformatics, 2010
Background Polymorphic variants and mutations disrupting canonical splicing isoforms are among the leading causes of human hereditary disorders. While there is a substantial evidence of aberrant splicing causing Mendelian diseases, the implication of ...
Hicks Chindo   +2 more
doaj   +2 more sources

AEP promotes aberrant RNA splicing through DDX3X cleavage in solid tumors

open access: yesThe Journal of Clinical Investigation
Aberrant alternative splicing (AS) events have been identified in a variety of cancers. Although somatic mutations of splicing factors and dysregulation of RNA-binding proteins (RBPs) have been linked to AS and tumor malignancy, it remains unclear how ...
Yadong Xie, Haohao Zhang, Xinyang Song
doaj   +2 more sources

saseR: juggling offsets unlocks RNA-seq tools for fast and scalable differential usage, aberrant splicing and expression retrieval

open access: yesGenome Biology
RNA-seq data analysis relies on many different tools, each tailored to specific applications and coming with unique assumptions and limitations. Indeed, tools for differential transcript usage or rare disease diagnosis through splicing and expression ...
Alexandre Segers   +5 more
doaj   +2 more sources

Aberrant splicing and drug resistance in AML [PDF]

open access: yesJournal of Hematology & Oncology, 2016
The advent of next-generation sequencing technologies has unveiled a new window into the heterogeneity of acute myeloid leukemia (AML). In particular, recurrent mutations in spliceosome machinery and genome-wide aberrant splicing events have been ...
Rosalia de Necochea-Campion   +4 more
doaj   +2 more sources

Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disorders [PDF]

open access: yesExperimental and Molecular Medicine
Effective translation of rare disease diagnosis knowledge into therapeutic applications is achievable within a reasonable timeframe; where mutations are amenable to current antisense oligonucleotide technology.
Htoo A. Wai   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy